Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation

被引：1
|
作者：
Jacoby, Ted V. [1 ,2 ]
Asdourian, Maria S. [2 ,3 ]
Shah, Nishi [2 ,4 ]
Otto, Tracey S. [2 ,5 ]
Thompson, Leah L. [2 ,3 ]
Reynolds, Kerry L. [6 ]
Chen, Steven T. [2 ,3 ]
机构：
[1] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI USA
[2] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02114 USA
[4] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[5] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[6] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2023年 / 48卷 / 09期
关键词：
D O I：
10.1093/ced/llad180
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1058 / 1060
页数：3
相关论文
共 50 条
  • [21] Rheumatic immune-related adverse events from cancer immunotherapy
    Calabrese, Leonard H.
    Calabrese, Cassandra
    Cappelli, Laura C.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) : 569 - 579
  • [22] A quantitative scoring system for cutaneous immune-related adverse events
    Hornick, N. I.
    Damo, M.
    Leventhal, J.
    Joshi, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (09) : B17 - B17
  • [23] Immune-related cutaneous adverse events due to checkpoint inhibitors
    Wang, Evelyn
    Kraehenbuehl, Lukas
    Ketosugbo, Kwami
    Kern, Jeffrey A.
    Lacouture, Mario E.
    Leung, Donald Y. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 613 - 622
  • [24] Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
    Allouchery, Marion
    Lombard, Thomas
    Martin, Mickael
    Rouby, Franck
    Sassier, Marion
    Bertin, Celia
    Atzenhoffer, Marina
    Miremont-Salame, Ghada
    Perault-Pochat, Marie-Christine
    Puyade, Mathieu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [25] HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
    Ning Jiang
    Yue Yu
    Dawei Wu
    Shuhang Wang
    Yuan Fang
    Huilei Miao
    Peiwen Ma
    Huiyao Huang
    Min Zhang
    Yu Zhang
    Yu Tang
    Ning Li
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 737 - 747
  • [26] HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
    Jiang, Ning
    Yu, Yue
    Wu, Dawei
    Wang, Shuhang
    Fang, Yuan
    Miao, Huilei
    Ma, Peiwen
    Huang, Huiyao
    Zhang, Min
    Zhang, Yu
    Tang, Yu
    Li, Ning
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 737 - 747
  • [27] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [28] Cutaneous immune-related adverse events to immune checkpoint inhibitors: A dermatology perspective
    Muntyanu, Anastasiya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB42 - AB42
  • [29] Treating Cutaneous Immune-Related Adverse Events from Immune Checkpoint Blockade
    Adusumilli, Nagasai C.
    Friedman, Adam J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (10) : 1133 - 1134
  • [30] Mechanisms underlying immune-related adverse events during checkpoint immunotherapy
    Zhou, Xiao
    Chen, Xiang
    Han, Leng
    Liu, Hong
    CLINICAL SCIENCE, 2022, 136 (10) : 771 - 785
12345